These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 14119854)
1. DISORDERS OF COAGULATION ASSOCIATED WITH SURGERY OF THE PROSTATE. ALLEN TD Tex State J Med; 1964 Feb; 60():155-61. PubMed ID: 14119854 [No Abstract] [Full Text] [Related]
5. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS]. OPPELT HG; BECK L Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686 [No Abstract] [Full Text] [Related]
6. [FIBRINOLYSIS IN UROLOGIC PATIENTS]. VELIKANOV KA Urol Mosc; 1964; 29():57-66. PubMed ID: 14185380 [No Abstract] [Full Text] [Related]
7. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS]. SAMAMA M Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287 [No Abstract] [Full Text] [Related]
8. Haemorrhagic diathesis, fibrinolysis and fibrinogenopenia in prostatic cancer. Report of a case. SIGSTAD H; LAMVIK J Acta Med Scand; 1963 Feb; 173():215-22. PubMed ID: 13989063 [No Abstract] [Full Text] [Related]
9. Disseminated intravascular coagulation: diagnosis and treatment of a hemorrhagic diathesis after prostatectomy. Pickens RL; Lattimer JK J Urol; 1972 Dec; 108(6):951-3. PubMed ID: 4117198 [No Abstract] [Full Text] [Related]
10. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. FLETCHER AP; ALKJAERSIG N; SHERRY S J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560 [No Abstract] [Full Text] [Related]
12. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. ALKJAERSIG N; FLETCHER AP; SHERRY S J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492 [No Abstract] [Full Text] [Related]
13. FIBRINOLYTIC HEMORRHAGE IN GENERAL SURGERY. TRINIDAD JC Philipp J Surg Surg Spec; 1963; 18():197-202. PubMed ID: 14059744 [No Abstract] [Full Text] [Related]
14. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS. HOAK JC; CONNOR WE; WARNER ED J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038 [No Abstract] [Full Text] [Related]
15. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy. BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646 [No Abstract] [Full Text] [Related]
16. [Therapy of acquired hemorrhagic diatheses]. Heene D; Schultis K Med Welt; 1968 Apr; 15():985-7. PubMed ID: 5305016 [No Abstract] [Full Text] [Related]
19. CANCER OF THE PROSTATE; A CLINICAL STUDY OF 131 PATIENTS. FISCHER-RASMUSSEN W; VILLUMSEN AL Dan Med Bull; 1963 Oct; 10():178-84. PubMed ID: 14067725 [No Abstract] [Full Text] [Related]
20. [CHRONIC FIBRINOLYSIS IN PROSTATIC CARCINOMA]. STOCKER H; MAIER C Schweiz Med Wochenschr; 1964 Sep; 94():1373-4. PubMed ID: 14323326 [No Abstract] [Full Text] [Related] [Next] [New Search]